Biotechnology

Techseriesinsight > Blog > News > Biotechnology

March 16, 2026
Business Wire
Biotechnology, News

Korsana Biosciences Appoints Mark Vignola, Ph.D., as Chief Financial Officer Share

Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that Mark Vignola, Ph.D., has...

March 13, 2026
Business Wire
Biotechnology, News

Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

A clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending December 31, 2025 and provided a business update....

March 13, 2026
PRNewswire
Biotechnology, News

PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement

PRISM BioLab Co., Ltd. (“PRISM”) and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the “Collaboration”) to develop an integrated, AI-navigated, physics-guided platform...

Jupiter Endovascular Announces Positive Results From SPIRARE

March 12, 2026
PRNewswire
Biotechnology, News

Carsten Bönnemann, MD, joins St. Jude to expand research on pediatric catastrophic neurological disorders

Bönnemann, who specializes in pediatric neuromuscular and neurogenetic disorders, comes to St. Jude from the National Institutes of Health, where he served as a physician-researcher and chief of the...

March 12, 2026
PRNewswire
Biotechnology, News

Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement

Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced it has been named a winner of a 2026 Asia Pacific Biopharma Excellence Award (ABEA). The company...

March 11, 2026
PRNewswire
Biotechnology, News

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to work across multiple viruses, today announced a collaboration...

March 10, 2026
PRNewswire
Biotechnology, News

Verana Health Enhances World Renowned RWD Ophthalmic Registry with Images

A digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has announced the establishment of an Imaging Consortium with leading Academic Medical Centers...

March 5, 2026
PRNewswire
Biotechnology, News

Bit Digital Inc. Reports Monthly Ethereum Treasury and Staking Metrics for February 2026

Today announced its monthly Ethereum (“ETH”) treasury and staking metrics for the month of February 2026: Key Highlights for February 2026 As of February 28, 2026, the Company held approximately 155,434.4[1] ETH....

March 5, 2026
PRNewswire
Biotechnology, News

RBL LLC Announces Launch of SteerBio with an up to $18.2 Million Federal Award to Pioneer a Curative Therapy for Lymphedema

A pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced that portfolio company SteerBio, a biotech startup developing a first-of-its-kind regenerative...

Netverge Introduces Artemis Dispatch: Natural-Language Reporting

March 5, 2026
Business Wire
Biotechnology, News

McKesson Announces Planned CFO Transition

McKesson Corporation (NYSE: MCK) today announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the...